Health Effects of Dental Amalgams in Children
The Children’s Amalgam Trial is one of only two randomized trials of its kind, and the only such trial in the United States, to address the potential impact of mercury exposure from amalgam restorations on neuropsychological and renal function in children.
Description
The safety of silver amalgam as a dental restorative material has been controversial since its introduction 150 years ago, but until recently it has been assumed that the exposure to mercury from dental amalgam is limited to the acute placement phase. However, some recent studies have raised safety concerns by demonstrating chronic release of mercury vapor from amalgam fillings during chewing and brushing. The Children’s Amalgam Trial (CAT) is a two-arm randomized trial of safety, comparing amalgam with a mercury-free restorative material. A single masking procedure is used to ensure that all investigators and staff measuring outcomes are unaware of assigned trial arm. The study follows 534 New England children, aged 6-10 years at enrollment, for 5 years. The children were recruited from two northeastern U.S. communities, one in rural Maine, and one in urban Massachusetts. No trial subjects received prior amalgam restorations, and all were in need of at least two posterior occlusal fillings. Participants were randomized to receive either amalgam or composite material for all posterior restorations at baseline and at subsequent visits. The primary endpoint will be 5-year change in IQ scores. Secondary endpoints will include measures of other neuropsychological assessments and renal functioning.
Status: Completed (Phase 3). Started on September 1st, 1997. Ended on March 1st, 2005.
Enrollment: 534 subjects
Study Type: Interventional
Study Design:
- Treatment
- Randomized
- Single Blind
- Active Control
- Single Group Assignment
- Safety Study
Conditions:
Interventions:
- Device: Dispersed phase amalgam restoration /composite restoration
Eligibility
6 - 10 years of age at last birthday
Fluent in English
No prior or existing amalgam restorations
Two or more posterior teeth with dental caries such that restoration would include the occlusal surfaces
No clinical evidence of existing psychological, behavioral, neurologic, immunosuppressive, or renal disorders.
- Gender
Both
- Mininum Age
6 Years
- Maximum Age
10 Years
- Healthy Volunteers
No
Resources
Source: National Institute of Dental and Craniofacial Research (NIDCR)
Authority: United States: Federal Government
Locations
-
New England Research Institute
Watertown
Massachusetts
02472
United States
Officials
Sonja M McKinlay (Principal Investigator, New England Research Institutes, Inc)
Sponsors
National Institute of Dental and Craniofacial Research (NIDCR) (Lead Sponsor)
References
None.
Links
None.
- Date Verified
- August 1st, 2005
- First Received
- May 2nd, 2006
- Last Changed
- May 2nd, 2006
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.
